Current Drug Targets : Impact Factor & More
eISSN: 1873-5592pISSN: 1389-4501
Share this on:
Key Metrics
CiteScore 
6.1
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.86
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Drug Targets
Current Drug Targets Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Drug Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Drug Targets
Drug Repurposing in Lung Cancer (NSCLC): Dual CDK1/TOP2A Targeting by Sertraline and Enoxacin.
- 6 May 2026
- Current drug targets
Innovative Nanoparticle-based Therapeutic Strategies: Overcoming Biological Barriers for Enhanced Efficacy.
- 6 May 2026
- Current drug targets
Target-based Antidiabetic Indole Derivatives and Insights into Structure-activity Relationships: A Mechanistic Update 2020-2025.
- 6 May 2026
- Current drug targets
Chronic Inflammation (A Silent Killer) - Molecular Mechanisms and Emerging Therapeutic Approaches.
- 6 May 2026
- Current drug targets
Decoding the Molecular Targets of Luteolin and Fisetin: Emerging Trends in Flavonoid-Based Therapeutics (A Systematic Review).
- 6 May 2026
- Current drug targets
(E)-Labda dial-Loaded Nanoparticles for Triple Negative Breast Cancer.
- 15 Apr 2026
- Current drug targets
Drug Repurposing in Lung Cancer (NSCLC): Dual CDK1/TOP2A Targeting by Sertraline and Enoxacin.
- 6 May 2026
- Current drug targets
Innovative Nanoparticle-based Therapeutic Strategies: Overcoming Biological Barriers for Enhanced Efficacy.
- 6 May 2026
- Current drug targets
Target-based Antidiabetic Indole Derivatives and Insights into Structure-activity Relationships: A Mechanistic Update 2020-2025.
- 6 May 2026
- Current drug targets
Chronic Inflammation (A Silent Killer) - Molecular Mechanisms and Emerging Therapeutic Approaches.
- 6 May 2026
- Current drug targets
Decoding the Molecular Targets of Luteolin and Fisetin: Emerging Trends in Flavonoid-Based Therapeutics (A Systematic Review).
- 6 May 2026
- Current drug targets
(E)-Labda dial-Loaded Nanoparticles for Triple Negative Breast Cancer.
- 15 Apr 2026
- Current drug targets
FAQs on Current Drug Targets
How long has Current Drug Targets been actively publishing? 
What is the publishing frequency of Current Drug Targets?
How many articles did Current Drug Targets publish last year?
What is the eISSN & pISSN for Current Drug Targets?
What is Citescore for Current Drug Targets?
What is SNIP score for Current Drug Targets?
What is the SJR for Current Drug Targets?
Who is the publisher of Current Drug Targets?
